Novel sublingual tablets of Atorvastatin calcium/ Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization

ConclusionsThe prepared sublingual tablets combining ATOR and TMZ will be a promising dosage form for coronary heart disease patients with an instant action and improved patient compliance.
Source: Saudi Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research